JP2018515526A5 - - Google Patents

Download PDF

Info

Publication number
JP2018515526A5
JP2018515526A5 JP2017559026A JP2017559026A JP2018515526A5 JP 2018515526 A5 JP2018515526 A5 JP 2018515526A5 JP 2017559026 A JP2017559026 A JP 2017559026A JP 2017559026 A JP2017559026 A JP 2017559026A JP 2018515526 A5 JP2018515526 A5 JP 2018515526A5
Authority
JP
Japan
Prior art keywords
salt
compound
pharmaceutical composition
formula
membered heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017559026A
Other languages
English (en)
Japanese (ja)
Other versions
JP6664414B2 (ja
JP2018515526A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/060481 external-priority patent/WO2016180843A1/en
Publication of JP2018515526A publication Critical patent/JP2018515526A/ja
Publication of JP2018515526A5 publication Critical patent/JP2018515526A5/ja
Application granted granted Critical
Publication of JP6664414B2 publication Critical patent/JP6664414B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017559026A 2015-05-13 2016-05-10 IGF−1R/IR阻害薬としての新規5,8−ジメチル−9−フェニル−5,8−ジヒドロ−6H−ピラゾロ[3,4−h]キナゾリン−2−イル)−(1H−ピラゾール−3−イル)−アミン及び誘導体 Active JP6664414B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15167553.5 2015-05-13
EP15167553 2015-05-13
PCT/EP2016/060481 WO2016180843A1 (en) 2015-05-13 2016-05-10 New 5,8-dimethyl-9-phenyl-5,8-dihydro-6h-pyrazolo[3,4-h]quinazolin-2- yl)-(1 h-pyrazol-3-yl)-amines and derivatives as igf-1 r/ir inhibitors

Publications (3)

Publication Number Publication Date
JP2018515526A JP2018515526A (ja) 2018-06-14
JP2018515526A5 true JP2018515526A5 (cg-RX-API-DMAC7.html) 2019-06-13
JP6664414B2 JP6664414B2 (ja) 2020-03-13

Family

ID=53181095

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017559026A Active JP6664414B2 (ja) 2015-05-13 2016-05-10 IGF−1R/IR阻害薬としての新規5,8−ジメチル−9−フェニル−5,8−ジヒドロ−6H−ピラゾロ[3,4−h]キナゾリン−2−イル)−(1H−ピラゾール−3−イル)−アミン及び誘導体

Country Status (4)

Country Link
US (1) US10414769B2 (cg-RX-API-DMAC7.html)
EP (1) EP3294742B1 (cg-RX-API-DMAC7.html)
JP (1) JP6664414B2 (cg-RX-API-DMAC7.html)
WO (1) WO2016180843A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016180843A1 (en) * 2015-05-13 2016-11-17 Boehringer Ingelheim International Gmbh New 5,8-dimethyl-9-phenyl-5,8-dihydro-6h-pyrazolo[3,4-h]quinazolin-2- yl)-(1 h-pyrazol-3-yl)-amines and derivatives as igf-1 r/ir inhibitors
US11066404B2 (en) 2018-10-11 2021-07-20 Incyte Corporation Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
WO2020168197A1 (en) 2019-02-15 2020-08-20 Incyte Corporation Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors
TW202100520A (zh) 2019-03-05 2021-01-01 美商英塞特公司 作為cdk2 抑制劑之吡唑基嘧啶基胺化合物
US11919904B2 (en) 2019-03-29 2024-03-05 Incyte Corporation Sulfonylamide compounds as CDK2 inhibitors
WO2020223558A1 (en) 2019-05-01 2020-11-05 Incyte Corporation Tricyclic amine compounds as cdk2 inhibitors
WO2020223469A1 (en) 2019-05-01 2020-11-05 Incyte Corporation N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer
WO2021030537A1 (en) 2019-08-14 2021-02-18 Incyte Corporation Imidazolyl pyrimidinylamine compounds as cdk2 inhibitors
JP2022545835A (ja) 2019-08-28 2022-10-31 ホライゾン セラピューティクス アイルランド デジグネイテッド アクティビティ カンパニー 甲状腺眼症の治療方法
CR20220170A (es) 2019-10-11 2022-10-10 Incyte Corp Aminas bicíclicas como inhibidoras de la cdk2
US11981671B2 (en) 2021-06-21 2024-05-14 Incyte Corporation Bicyclic pyrazolyl amines as CDK2 inhibitors
US11976073B2 (en) 2021-12-10 2024-05-07 Incyte Corporation Bicyclic amines as CDK2 inhibitors
CN122003247A (zh) 2023-07-07 2026-05-08 维里迪安治疗公司 治疗活动性和慢性甲状腺眼病的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8735386B2 (en) * 2010-07-23 2014-05-27 Boehringer Ingelheim International Gmbh Aminopyrazoloquinazolines
EP2807166B1 (en) 2012-01-23 2016-04-06 Boehringer Ingelheim International GmbH 5,8-dihydro-6h-pyrazolo[3,4-h]quinazolines as igf-1r/ir inhibitors
WO2016180843A1 (en) * 2015-05-13 2016-11-17 Boehringer Ingelheim International Gmbh New 5,8-dimethyl-9-phenyl-5,8-dihydro-6h-pyrazolo[3,4-h]quinazolin-2- yl)-(1 h-pyrazol-3-yl)-amines and derivatives as igf-1 r/ir inhibitors

Similar Documents

Publication Publication Date Title
CA3218237A1 (en) Quinazoline derivatives useful as ras inhibitiors
DK2017278T3 (en) DIHYDROPYRAZOLOPYRIMIDINON DERIVATIVES
JP5925808B2 (ja) 三環式誘導体、これらの調製方法およびこれらのキナーゼ阻害剤としての使用
US9938264B2 (en) Proteolysis targeting chimera compounds and methods of preparing and using same
CN111741954B (zh) 用作egfr抑制剂的新型苯并咪唑化合物及衍生物
EP2788351B1 (en) SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASE INHIBITORS
EP2101759B1 (en) Methods of using mek inhibitors
ES2558780T3 (es) Imidazopiridazinas como inhibidores de la cinasa Akt
RU2006121337A (ru) Производные пиразола и их применение в качестве ингибиторов рецепторных тирозинкиназ
CA2683641A1 (en) Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha
AU2004289672A1 (en) Inhibition of FGFR3 and treatment of multiple myeloma
EA036013B1 (ru) Новые спиро[3h-индол-3,2'-пирролидин]-2(1h)-оновые соединения и производные в качестве ингибиторов mdm2-p53
EA038071B1 (ru) СОЕДИНЕНИЕ СПИРО[3H-ИНДОЛ-3,2'-ПИРРОЛИДИН]-2(1H)-ОНА И ЕГО ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ MDM2-p53
JP2017508763A (ja) 5−置換インダゾール−3−カルボキサミドならびにその調製および使用の方法
CN105960407A (zh) 用于治疗炎症障碍的新盐类及其药物组合物
EP2935260A1 (de) Bet-proteininhibitorische dihydropyridopyrazinone
WO2012035423A1 (en) Anti-cancer activity of novel bicyclic heterocycles
EP2376493A1 (en) Dihydropyrimidopyrimidine derivative
TR201816387T4 (tr) Bisiklik heterosikllerin antiviral aktivitesi.
WO2018141002A2 (en) DERIVATIVES OF N-CYCLOALKYL/HETEROCYCLOALKYL-4-(IMIDAZO [1,2-a]PYRIDINE)PYRIMIDIN-2-AMINE AS THERAPEUTIC AGENTS
JPWO2021060453A5 (cg-RX-API-DMAC7.html)
KR20240089275A (ko) 피롤로[2,1-f][1,2,4]트리아진 및 그의 제조 및 용도
JP2004517960A (ja) 抗エストロゲン剤とファルネシルプロテイントランスフェラーゼ阻害剤の組み合わせ
WO2014177915A1 (en) Cancer combination therapy using imidazo[4,5-c]quinoline derivatives
RU2443418C2 (ru) КОМБИНАЦИЯ ПИРИМИДИЛАМИНОБЕНЗАМИДА И ИНГИБИТОРА КИНАЗ mTOR